Literature DB >> 17669394

TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.

Thiago M Cunha1, Waldiceu A Verri, Sandra Y Fukada, Ana T G Guerrero, Tania Santodomingo-Garzón, Stephen Poole, Carlos A Parada, Sergio H Ferreira, Fernando Q Cunha.   

Abstract

Kinin receptors are involved in the genesis of inflammatory pain. However, there is controversy concerning the mechanism by which B(1) and B(2) kinin receptors mediate inflammatory hypernociception. In the present study, the role of these receptors on inflammatory hypernociception in mice was addressed. Mechanical hypernociception was detected with an electronic pressure meter paw test in mice and cytokines were measured by ELISA. It was observed that in naïve mice a B(2) (d-Arg-Hyp(3), d-Phe(7)-bradykinin) but not a B(1) kinin receptor antagonist (des-Arg(9)-[Leu(8)]-bradykinin, DALBK) inhibited bradykinin- and carrageenin-induced hypernociception. Bradykinin-induced hypernociception was inhibited by indomethacin (5 mg/kg) and guanethidine (30 mg/kg), while not affected by IL-1ra (10 mg/kg) or antibody against keratinocyte-derived chemokine (KC/CXCL-1, 500 ng/paw) or in TNFR1 knockout mice. By contrast, in previously lipopolysaccharide (LPS)-primed mouse paw, B(1) but not B(2) kinin receptor antagonist inhibited bradykinin hypernociception. Furthermore, B(1) kinin receptor agonist induced mechanical hypernociception in LPS-primed mice, which was inhibited by indomethacin, guanethidine, antiserum against TNF-alpha or IL-1ra. This was corroborated by the induction of TNF-alpha and IL-1beta release by B(1) kinin receptor agonist in LPS-primed mouse paws. Moreover, B(1) but not B(2) kinin receptor antagonist inhibited carrageenin-induced hypernociception, and TNF-alpha and IL-1beta release as well, in LPS-primed mice. These results suggest that in naïve mice the B(2) kinin receptor mediates inflammatory hypernociception dependent on prostanoids and sympathetic amines, through a cytokine-independent mechanism. On the other hand, in LPS-primed mice, the B(1) kinin receptor mediates hypernociception by a mechanism dependent on TNF-alpha and IL-1beta, which could stimulate prostanoid and sympathetic amine production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669394     DOI: 10.1016/j.ejphar.2007.07.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

Review 1.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

Review 2.  Ion channels in inflammation.

Authors:  Michael Eisenhut; Helen Wallace
Journal:  Pflugers Arch       Date:  2011-01-29       Impact factor: 3.657

3.  Female- and Intruder-induced Ultrasonic Vocalizations in C57BL/6J Mice as Proxy Indicators for Animal Wellbeing.

Authors:  Brian J Smith; Kate E P Bruner; Lon V Kendall
Journal:  Comp Med       Date:  2019-10-02       Impact factor: 0.982

4.  Photobiomodulation therapy in the modulation of inflammatory mediators and bradykinin receptors in an experimental model of acute osteoarthritis.

Authors:  Vanessa Lima Cavalcante de Oliveira; José Antonio Silva; Andrey Jorge Serra; Rodney Capp Pallotta; Evela Aparecida Pereira da Silva; Anna Cristina de Farias Marques; Regiane Dos Santos Feliciano; Rodrigo Labat Marcos; Ernesto Cesar Pinto Leal-Junior; Paulo de Tarso Camillo de Carvalho
Journal:  Lasers Med Sci       Date:  2016-10-10       Impact factor: 3.161

5.  Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation.

Authors:  Thiago M Cunha; Jhimmy Talbot; Larissa G Pinto; Silvio M Vieira; Guilherme R Souza; Ana T Guerrero; Fabiane Sonego; Waldiceu A Verri; Dario S Zamboni; Sergio H Ferreira; Fernando Q Cunha
Journal:  Mol Pain       Date:  2010-10-04       Impact factor: 3.395

Review 6.  Cytokine and chemokine regulation of sensory neuron function.

Authors:  Richard J Miller; Hosung Jung; Sonia K Bhangoo; Fletcher A White
Journal:  Handb Exp Pharmacol       Date:  2009

7.  B1 and B2 kinin receptor blockade improves psoriasis-like disease.

Authors:  Bruna da Silva Soley; Leonardo Martins Silva; Daniel Augusto Gasparin Bueno Mendes; André Báfica; João Bosco Pesquero; Michael Bader; Deborah A Witherden; Wendy L Havran; João B Calixto; Michel Fleith Otuki; Daniela Almeida Cabrini
Journal:  Br J Pharmacol       Date:  2020-05-30       Impact factor: 8.739

8.  IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice.

Authors:  Waldiceu A Verri; Ana T G Guerrero; Sandra Y Fukada; Daniel A Valerio; Thiago M Cunha; Damo Xu; Sérgio H Ferreira; Foo Y Liew; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

9.  Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.

Authors:  Fernanda Virginia Barreto Mota; Marlene Saraiva de Araújo Neta; Eryvelton de Souza Franco; Isla Vanessa Gomes Alves Bastos; Larissa Cardoso Correia da Araújo; Sandra Cabral da Silva; Tatiane Bezerra de Oliveira; Eduarda Karynne Souza; Valderes Moraes de Almeida; Rafael Matos Ximenes; Maria Bernadete de Sousa Maia; Francisco Jaime Bezerra Mendonça Junior; Pascal Marchand; Antônio Rodolfo de Faria; Teresinha Gonçalves da Silva
Journal:  Medchemcomm       Date:  2019-09-12       Impact factor: 3.597

10.  The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi.

Authors:  Julio Scharfstein; Daniele Andrade; Erik Svensjö; Ana Carolina Oliveira; Clarissa R Nascimento
Journal:  Front Immunol       Date:  2013-01-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.